Patent Cliff · Pharmaceutical
Pharmaceuticals patent cliff
The pharmaceutical patent cliff: blockbuster drugs including biologics and small molecules from the 2000s face imminent patent expiry, opening generics and biosimilar competition.
Expiring 2025–2029
1
Citations at stake
322
Peak cliff year
2026
Already expired
13
Patents Expiring by Year (2025–2029)
2025
0
2026
1
2027
0
2028
0
2029
0
Most-Cited Pharmaceutical Patents Expiring 2025–2029
Year-by-Year Top Patents
Strategic context
The pharmaceutical patent cliff: blockbuster drugs including biologics and small molecules from the 2000s face imminent patent expiry, opening generics and biosimilar competition. As these patents expire, competitors and open-source projects can freely implement the underlying inventions without license fees. For FTO analysis on specific products, use the FTO Risk Snapshot tool →
Other domain cliffs